Welcome to our dedicated page for P3 HEALTH PARTNERS news (Ticker: PIII), a resource for investors and traders seeking the latest updates and insights on P3 HEALTH PARTNERS stock.
P3 Health Partners Inc. (NASDAQ: PIII) is a physician-led, patient-centered population health management company that regularly issues news and updates related to its value-based care activities, Medicare membership, and financial performance. As a company focused on supporting primary care providers with care coordination and administrative services, P3’s news flow often highlights developments in its population health platform and provider network.
Investors and healthcare observers following PIII news can expect recurring coverage of quarterly earnings results, guidance updates, and discussions of non-GAAP metrics such as Adjusted EBITDA and medical margin. The company frequently reports on trends in at-risk Medicare membership, medical cost patterns, and the performance of its care enablement model across its markets.
P3 Health Partners also announces strategic partnerships and joint ventures, including the formation of P3 Commonwealth Innovation MSO, LLC with Commonwealth Primary Care ACO, LLC. Such releases describe how P3 engages in management, administration, and coordination of activities for accountable care organizations, including shared services, financial management, compliance operations, data analytics, and clinical integration.
Additional PIII news items cover participation in investor conferences, scheduling of earnings calls and webcasts, and operational milestones such as multi-state implementations with service partners. These updates provide insight into how P3 works with affiliated primary care providers, manages value-based arrangements, and navigates its multi-state footprint in markets such as Arizona, California, Nevada, and Oregon.
By reviewing the P3 Health Partners news page, readers can follow the company’s ongoing disclosures about its population health management strategy, financial results, ACO-related initiatives, and interactions with the investment community.
P3 Health Partners announced a definitive agreement for a $42.2 million private placement with institutional investors, led by affiliates of Chicago Pacific Founders (CPF). The company will issue approximately 67.4 million units at $0.6270 per unit, each including one share of Class A common stock and a warrant to buy another share at $0.5020. Net proceeds will be used for working capital and general corporate purposes. Closing is expected around May 24, 2024, subject to conditions. William Blair & Company served as the sole placement agent.
P3 Health Partners Inc. (NASDAQ: PIII) reported the approval of employment inducement equity grants to Aric Coffman, M.D., who will serve as the Chief Executive Officer and President. The grants include a stock option for 12,100,000 Class A shares of Common Stock and a restricted stock unit (RSU) award for 4,400,000 shares of Common Stock. Both awards are subject to vesting conditions based on Dr. Coffman's employment and the company's performance.
P3 Health Partners announced its first quarter 2024 results, showcasing a 29% year-over-year revenue growth. Dr. Aric Coffman joined as CEO, with a focus on achieving profitability in 2024. The company reaffirmed its 2024 guidance, aiming for Adjusted EBITDA positivity. Total revenue was $388.5 million, capitated revenue saw a significant increase, but gross profit saw a decline. The net loss improved slightly, while Adjusted EBITDA loss also increased. Fiscal 2024 guidance outlines ambitious targets for at-risk members, total revenues, medical margin, and Adjusted EBITDA.
P3 Health Partners Inc. announced that Dr. Aric Coffman has been appointed as the new CEO, effective May 8, 2024, succeeding Dr. Sherif Abdou. Dr. Abdou will continue as a Strategic Advisor and Board member. Dr. Coffman brings extensive experience in value-based care and healthcare delivery for seniors, with a successful track record in leadership roles. The appointment reflects the company's focus on growth and success in the value-based care sector.
P3 Health Partners Inc. (NASDAQ: PIII) announced the schedule for its first quarter 2024 earnings release and conference call. The financial results will be released on May 8, 2024, followed by a conference call to discuss the results at 1:30pm PT/ 4:30pm ET on the same day.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.